FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Daiji Kato

Research Profile

Disorders

Chemicals & Drugs

Geographic Areas

Japan

Physiology

Living Beings

Asian Continental Ancestry Group

Concepts & Ideas

Genes & Molecular Sequences

Alleles

Procedures

Co-author Network

Publications

TOP 3
Akira Suda; Chiaki Kawanishi; Ikuko Kishida; Ryoko Sato; Tomoki Yamada; Makiko Nakagawa; Hana Hasegawa; Daiji Kato; Taku Furuno; Yoshio Hirayasu
Dopamine D2 receptor gene polymorphisms are associated with suicide attempt in the Japanese population.
Chiaki Kawanishi; Hideki Onishi; Daiji Kato; Ikuko Kishida; Taku Furuno; Makoto Wada; Yoshio Hirayasu
Unexpectedly high prevalence of akathisia in cancer patients.
Daiji Kato; Chiaki Kawanishi; Ikuko Kishida; Taku Furuno; Kyoko Suzuki; Hideki Onishi; Yoshio Hirayasu
Effects of CYP2D6 polymorphisms on neuroleptic malignant syndrome.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Daiji Kato (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Akira Suda; Chiaki Kawanishi; Ikuko Kishida; Ryoko Sato; Tomoki Yamada; Makiko Nakagawa; Hana Hasegawa; Daiji Kato; Taku Furuno; Yoshio Hirayasu
Dopamine D2 receptor gene polymorphisms are associated with suicide attempt in the Japanese population.
Neuropsychobiology 2009;59(2):130-4.
2007: Chiaki Kawanishi; Hideki Onishi; Daiji Kato; Ikuko Kishida; Taku Furuno; Makoto Wada; Yoshio Hirayasu
Unexpectedly high prevalence of akathisia in cancer patients.
Palliative & supportive care 2007;5(4):351-4.
2007: Daiji Kato; Chiaki Kawanishi; Ikuko Kishida; Taku Furuno; Kyoko Suzuki; Hideki Onishi; Yoshio Hirayasu
Effects of CYP2D6 polymorphisms on neuroleptic malignant syndrome.
European journal of clinical pharmacology 2007;63(11):991-6.
2007: Tomohide Roppongi; Takashi Togo; Shinichi Nakamura; Takeshi Asami; Asuka Yoshimi; Kazumasa Shiozaki; Daiji Kato; Chiaki Kawanishi; Yoshio Hirayasu
Perospirone in treatment of Huntington's disease: a first case report.
Progress in neuro-psychopharmacology & biological psychiatry 2007;31(1):308-10.
2007: Tomoki Yamada; Chiaki Kawanishi; Hana Hasegawa; Ryoko Sato; Akiko Konishi; Daiji Kato; Taku Furuno; Ikuko Kishida; Toshinari Odawara; Mitsugi Sugiyama; Yoshio Hirayasu
Psychiatric assessment of suicide attempters in Japan: a pilot study at a critical emergency unit in an urban area.
BMC psychiatry 2007;7():64.
2006: Ryoko Sato; Chiaki Kawanishi; Tomoki Yamada; Hana Hasegawa; Haruka Ikeda; Daiji Kato; Taku Furuno; Ikuko Kishida; Yoshio Hirayasu
Knowledge and attitude towards suicide among medical students in Japan: preliminary study.
Psychiatry and clinical neurosciences 2006;60(5):558-62.
2006: Makiko Nakagawa; Takehiko Matsumura; Daiji Kato; Ikuko Kishida; Chiaki Kawanishi; Kouichi Tamura; Yoshio Hirayasu
Neuroleptic malignant syndrome induced by perospirone.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2006;9(5):635-6.
2006: Akiko Kobayashi; Chiaki Kawanishi; Takehiko Matsumura; Daiji Kato; Ryoko Furukawa; Ikuko Kishida; Yoshio Hirayasu
Quetiapine-induced neuroleptic malignant syndrome in dementia with Lewy bodies: a case report.
Progress in neuro-psychopharmacology & biological psychiatry 2006;30(6):1170-2.
2005: Daiji Kato; Chiaki Kawanishi; Ikuko Kishida; Taku Furuno; Takehiko Matsumura; Hana Hasegawa; Kyoko Suzuki; Yoshio Hirayasu
CYP2D6 gene deletion allele in patients with neuroleptic malignant syndrome: preliminary report.
Psychiatry and clinical neurosciences 2005;59(4):504-7.
2005: Daiji Kato; Chiaki Kawanishi; Ikuko Kishida; Taku Furuno; Takehiko Matsumura; Hana Hasegawa; Yoshio Hirayasu
Delirium resolving upon switching from risperidone to quetiapine: implication of CYP2D6 genotype.
Psychosomatics 2005;46(4):374-5.
2005: Chiaki Kawanishi; Hideki Onishi; Daiji Kato; Tomoki Yamada; Masanari Onose; Yoshio Hirayasu
Neuroleptic malignant syndrome in cancer treatment.
Palliative & supportive care 2005;3(1):51-3.
2004: Hiroyuki Narita; Toshinari Odawara; Toshihiko Matsumoto; Shigeru Kimura; Tomoki Yamada; Eizo Iseki; Kazuya Miyakawa; Hiroaki Hino; Daiji Kato; Kenji Kosaka; Yoshio Hirayasu
[A case with late-onset MELAS with hallucination and delusion].
Nō to shinkei = Brain and nerve 2004;56(4):345-9.
2004: Ikuko Kishida; Chiaki Kawanishi; Taku Furuno; Daiji Kato; T Ishigami; Kenji Kosaka
Association in Japanese patients between neuroleptic malignant syndrome and functional polymorphisms of the dopamine D(2) receptor gene.
Molecular psychiatry 2004;9(3):293-8.